OPKO HEALTH, INC. (OPK)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 700M 1.4B 2.1B Q3 '21: 1.9B Q4 '21: 1.8B Q1 '22: 1.6B Q2 '22: 1.4B Q3 '22: 1.2B Q4 '22: 1B Q1 '23: 912.6M Q2 '23: 868.1M Q3 '23: 866.9M Q4 '23: 863.5M Q1 '24: 799.6M Q2 '24: 716.4M Q3 '24: 711.4M Q4 '24: 713.1M Q1 '25: 689.4M Q2 '25: 664M Q3 '25: 642.1M Q4 '25: 606.9M Q1 '26: 581.1M Q2 '26: 587.9M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit TTM

0 90M 180M 270M Q4 '10: 15M Q1 '11: 16.6M Q2 '11: 17.5M Q3 '11: 18M Q2 '12: 11.9M Q3 '12: 13.4M Q4 '12: 37.7M Q1 '13: 53.6M Q2 '13: 91.7M Q3 '13: 127M Q4 '13: 157.6M Q4 '24: 218.5M Q1 '25: 219.1M Q2 '25: 216.8M Q3 '25: 226.6M Q4 '25: 205.9M Q1 '26: 209.1M Q2 '26: 239.7M Q2 '11 Q3 '12 Q2 '13 Q4 '24 Q3 '25 Q2 '26

Operating Income TTM

-300M -200M -100M 0 100M 200M 300M Q3 '20: -104.1M Q4 '20: 57.7M Q1 '21: 136.9M Q2 '21: 115.3M Q3 '21: 131.2M Q4 '22: -226.3M Q1 '23: -184.4M Q2 '23: -166.7M Q3 '23: -143.2M Q4 '23: -157M Q1 '24: -197.9M Q2 '24: -266.6M Q3 '24: -269.4M Q4 '24: -233.4M Q1 '25: -229.1M Q2 '25: -227.5M Q3 '25: -112.2M Q4 '25: -117.4M Q1 '26: -101.3M Q2 '26: -48.2M Q4 '20 Q3 '21 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income TTM

-450M -300M -150M 0 150M 300M 450M Q3 '21: 75.9M Q4 '21: -30.1M Q1 '22: -116.7M Q2 '22: -202.1M Q3 '22: -316.9M Q4 '22: -328.4M Q1 '23: -291.2M Q2 '23: -209.2M Q3 '23: -207.6M Q4 '23: -188.9M Q1 '24: -252.4M Q2 '24: -243.1M Q3 '24: -133.7M Q4 '24: -53.2M Q1 '25: -39M Q2 '25: -177.1M Q3 '25: -180.4M Q4 '25: -225.7M Q1 '26: -212.9M Q2 '26: -72.9M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue TTM

0 200M 400M 600M Q4 '10: 13.5M Q1 '11: 15.7M Q2 '11: 15.8M Q3 '11: 16.4M Q2 '12: 19.7M Q3 '12: 23.2M Q4 '12: 27.9M Q1 '13: 34.6M Q2 '13: 41.2M Q3 '13: 45.7M Q4 '24: 494.6M Q1 '25: 470.3M Q2 '25: 447.2M Q3 '25: 415.5M Q4 '25: 400.9M Q1 '26: 372M Q2 '26: 348.2M Q1 '11 Q2 '12 Q1 '13 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow TTM

-270M -180M -90M 0 90M 180M 270M Q3 '21: 78.2M Q4 '21: 38.3M Q1 '22: -7.6M Q2 '22: -3.6M Q3 '22: -69.2M Q4 '22: -95.2M Q1 '23: -98M Q2 '23: -86.9M Q3 '23: -21.5M Q4 '23: -28.2M Q1 '24: -41.1M Q2 '24: -67.2M Q3 '24: -177.4M Q4 '24: -183.5M Q1 '25: -182.5M Q2 '25: -239.5M Q3 '25: -197M Q4 '25: -178.5M Q1 '26: -163.3M Q2 '26: -123.4M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow TTM

-270M -180M -90M 0 90M 180M 270M Q3 '21: 46M Q4 '21: 6.2M Q1 '22: -35.7M Q2 '22: -28.2M Q3 '22: -94.2M Q4 '22: -119.8M Q1 '23: -120.3M Q2 '23: -109.9M Q3 '23: -41.1M Q4 '23: -44.5M Q1 '24: -58.8M Q2 '24: -86.1M Q3 '24: -200M Q4 '24: -208.5M Q1 '25: -206.2M Q2 '25: -259.3M Q3 '25: -212.1M Q4 '25: -190.8M Q1 '26: -174.2M Q2 '26: -134M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 350M 700M 1.1B Q2 '18: 559.5M Q2 '20: 640.6M Q3 '20: 640.7M Q1 '21: 640.9M Q2 '21: 647M Q3 '21: 651.8M Q1 '22: 660.3M Q2 '22: 712.5M Q3 '22: 750.4M Q1 '23: 751.5M Q2 '23: 751.7M Q3 '23: 751.5M Q1 '24: 706.9M Q2 '24: 697.2M Q3 '24: 998.4M Q1 '25: 671.6M Q2 '25: 788M Q3 '25: 779.9M Q1 '26: 758.9M Q2 '26: 755.3M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.45 -0.30 -0.15 0.00 0.15 0.30 0.45 Q3 '21: 0.11 Q4 '21: -0.05 Q1 '22: -0.18 Q2 '22: -0.29 Q3 '22: -0.44 Q4 '22: -0.44 Q1 '23: -0.38 Q2 '23: -0.27 Q3 '23: -0.27 Q4 '23: -0.25 Q1 '24: -0.35 Q2 '24: -0.33 Q3 '24: -0.19 Q4 '24: -0.09 Q1 '25: -0.07 Q2 '25: -0.25 Q3 '25: -0.25 Q4 '25: -0.30 Q1 '26: -0.27 Q2 '26: -0.09 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.